Did you miss this #acneceuticals article from April’s issue? What if your acne routine could be smarter, more personalized—and actually stick? Say hello to the new acne algorithm that’s changing…
Read More
Spotlight on Rosacea: Beyond the Redness This National Rosacea Month April marks National Rosacea Month, a timely reminder for dermatology professionals to sharpen their diagnostic lens beyond textbook erythema. While…
Read More
Listen Now! Dermatology is always evolving, and if you haven’t caught the latest "Ask the Investigator" podcast episodes, you're missing out on game-changing insights! Hosted by the always-engaging Dr. Adam…
Read More
Did You Miss It? Micronized isotretinoin is an established treatment for severe nodular acne, but can it be effectively dosed once daily instead of twice? A new pilot study explores…
Read More
Acneceuticals: A New Era in Acne Care? Pharmaceuticals and procedures have long been the backbone of acne treatment, but over-the-counter skincare is playing an increasingly recognized role. This new paper…
Read More
A recent Journal of Drugs in Dermatology study about a micropeptide with anti-aging and anti-inflammatory effects made news in Dermatology Times. The study, “Acetyl Dipeptide-31 Amide: A Novel Cosmetic Anti-Inflammatory…
Read More
Featured Podcast Don't pop, rather pick a therapeutic strategy from the wide array of new….oh wait, nevermind. The world of acne treatment R&D is unfortunately shrinking as payors pick away…
Read More
JDD Article Highlight Treating acne isn’t just about prescriptions—it’s about pairing the right skincare routine with medical therapy. This JDD article highlights how combining pharmacological treatments with a personalized dermocosmetic regimen…
Read More
By Allison Sit Dermatology Advisor and Physician’s Weekly each shared a HealthDay article about a JDD study on a possible relationship between hyperhidrosis and sensitive skin. The study, “Primary Hyperhidrosis…
Read More
JDD Article Highlights Triple-combination therapies for acne are known for their efficacy, but the complexity of multiple treatments often reduces patient adherence. Enter CAB gel (Clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide…
Read More
by Allison Sit Healio wrote about two JDD studies on psoriasis treatments including one on the benefits of long-term ixekizumab. The study, “Benefits Over Five Years of Ixekizumab Treatment in…
Read More
JDD Article Highlight JDD’s article titled “To Acne and Beyond: A Review of Sarecycline’s Off-Label Uses” discusses how sarecycline, a third-generation tetracycline, is FDA-approved for moderate to severe acne in patients…
Read More
